DE69428455D1 - Verfahren zur herstellung von niedrigdosierten arzneimitteln - Google Patents

Verfahren zur herstellung von niedrigdosierten arzneimitteln

Info

Publication number
DE69428455D1
DE69428455D1 DE69428455T DE69428455T DE69428455D1 DE 69428455 D1 DE69428455 D1 DE 69428455D1 DE 69428455 T DE69428455 T DE 69428455T DE 69428455 T DE69428455 T DE 69428455T DE 69428455 D1 DE69428455 D1 DE 69428455D1
Authority
DE
Germany
Prior art keywords
medicinal products
producing low
low
dose medicinal
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69428455T
Other languages
English (en)
Other versions
DE69428455T2 (de
DE69428455T3 (de
Inventor
Frank C Greaves
James Swarbrick
Martin W Beasley
Andrew W Suddith
Henry C Caldwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Barr Pharmaceuticals Inc
Original Assignee
Endeavor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25583539&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69428455(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Endeavor Pharmaceuticals Inc filed Critical Endeavor Pharmaceuticals Inc
Publication of DE69428455D1 publication Critical patent/DE69428455D1/de
Publication of DE69428455T2 publication Critical patent/DE69428455T2/de
Application granted granted Critical
Publication of DE69428455T3 publication Critical patent/DE69428455T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69428455T 1993-12-21 1994-12-20 Verfahren zur herstellung von niedrigdosierten arzneimitteln Expired - Lifetime DE69428455T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA939565A ZA939565B (en) 1993-12-21 1993-12-21 Method for preparing low dose pharmaceutical products.
ZA9309565 1993-12-21
PCT/US1994/014638 WO1995017168A1 (en) 1993-12-21 1994-12-20 Method for preparing low dose pharmaceutical products

Publications (3)

Publication Number Publication Date
DE69428455D1 true DE69428455D1 (de) 2001-10-31
DE69428455T2 DE69428455T2 (de) 2002-05-29
DE69428455T3 DE69428455T3 (de) 2005-01-20

Family

ID=25583539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69428455T Expired - Lifetime DE69428455T3 (de) 1993-12-21 1994-12-20 Verfahren zur herstellung von niedrigdosierten arzneimitteln

Country Status (6)

Country Link
EP (1) EP0735864B2 (de)
AT (1) ATE206042T1 (de)
AU (1) AU1515595A (de)
DE (1) DE69428455T3 (de)
WO (1) WO1995017168A1 (de)
ZA (1) ZA939565B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ289081B6 (cs) * 1994-09-22 2001-10-17 Akzo Nobel N. V. Způsob výroby farmaceutické lékové formy a tableta
AR004178A1 (es) * 1995-07-29 1998-11-04 Smithkline Beecham Plc Procedimiento para la formulacion de un farmaco, una composicion farmaceutica obtenible mediante este procedimiento y el uso de la misma.
WO1999036030A2 (en) * 1998-01-16 1999-07-22 Davitz, Michael, A. Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions
EP1974724A3 (de) * 2000-09-22 2008-11-12 Dainippon Sumitomo Pharma Co., Ltd. Orale Zubereitungen mit vorteilhaften Zerfallseigenschaften
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
JP2007532511A (ja) * 2004-04-09 2007-11-15 スミスクライン ビーチャム コーポレーション 低用量医薬品
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
US9339466B2 (en) 2010-03-23 2016-05-17 Siga Technologies, Inc. Polymorphic forms of ST-246 and methods of preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2146239A1 (de) † 1970-09-25 1972-03-30 CIBA Geigy AG, Basel (Schweiz) Neue antikonzeptionelle Mittel
DE2310963A1 (de) † 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
US3969502A (en) † 1972-04-14 1976-07-13 Schering Aktiengesellschaft Method for contraception by the administration of sequential contraceptive preparations
SE457326B (sv) † 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
US5073374A (en) * 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
EP0735864B2 (de) 2004-09-01
ATE206042T1 (de) 2001-10-15
EP0735864A1 (de) 1996-10-09
JP3883204B2 (ja) 2007-02-21
JPH09506899A (ja) 1997-07-08
AU1515595A (en) 1995-07-10
DE69428455T2 (de) 2002-05-29
DE69428455T3 (de) 2005-01-20
EP0735864B1 (de) 2001-09-26
WO1995017168A1 (en) 1995-06-29
ZA939565B (en) 1994-08-11

Similar Documents

Publication Publication Date Title
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
KR880010758A (ko) 서방성 제제
AU587281B2 (en) Slow-release pharmaceutical agent
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
EP0875245A3 (de) Polymermischung enthaltende Matrix mit verzögerter Wirkstoffabgabe für pharmazeutische Verwendungen
IL90435A (en) 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them
YU31599A (sh) Brzo oslobadjajući i za ukus maskirajući farmaceutski oblik doze
ES2110212T3 (es) Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion.
DE69428455D1 (de) Verfahren zur herstellung von niedrigdosierten arzneimitteln
AT382076B (de) Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
ATE169818T1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
CA2176461A1 (en) Method for preparing low dose pharmaceutical products
DE69103724T2 (de) Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren.
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
ES2082524T3 (es) Medicamento de liberacion retardada que contiene un derivado de dihidropiridina en forma de nanosol y su preparacion.
RU93027376A (ru) Получение таблетки, содержащей интерферон-альфа, для энтерального применения и ее состав
NO964775L (no) Fast farmasöytisk adenosinholdig preparat

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: BARR LABORATORIES, INC., WOODCLIFF LAKE, N.J., US